论文部分内容阅读
目的:探讨缬沙坦治疗急性心肌梗死合并心功不全的临床价值。方法:选取重庆市涪陵协和医院心内科2013年2月-2014年4月收治的117例患者,随机分为观察组与对照组,在常规治疗的基础上,分别给予缬沙坦与依那普利治疗。结果:两组血压值均较治疗前有所下降,组间比较,差异无统计学意义(P>0.05);两组LVEF、LVEDD均较治疗前有所改善,差异具有统计学意义(P<0.05),且观察组改善更明显,差异具有统计学意义(P<0.05)。结论:急性心肌梗死合并心功不全患者采用缬沙坦治疗效果肯定,患者心室重构得到改善。
Objective: To investigate the clinical value of valsartan in the treatment of acute myocardial infarction complicated with cardiac insufficiency. Methods: A total of 117 patients admitted from April 2014 to April 2014 in Fuling Xiehe Hospital of Chongqing were randomly divided into observation group and control group. On the basis of routine treatment, valsartan and enalapril Lee treatment. Results: The blood pressure of both groups decreased compared with those before treatment. There was no significant difference between the two groups (P> 0.05). The LVEF and LVEDD of both groups were improved before treatment, with statistical significance (P < 0.05), and the observation group improved more significantly, the difference was statistically significant (P <0.05). Conclusion: The treatment effect of valsartan in patients with acute myocardial infarction complicated with cardiac insufficiency is positive, and ventricular remodeling is improved.